Online Course: Recent Decisions of the EPO Boards of Appeal in Biotechnology and Biopharmaceuticals

Seminar

Online

Preis auf Anfrage

Beschreibung

  • Kursart

    Seminar

  • Methodik

    Online

The most important published and unpublished decisions of the EPO Boards of Appeal 2016-2018 in the field of biotechnology will be presented. The panelists will discuss, in particular, the consequences of these decisions on patent practice.

Fragen & Antworten

Ihre Frage hinzufügen

Unsere Berater und andere Nutzer werden Ihnen antworten können

Wer möchten Sie Ihre Frage beantworten?

Geben Sie Ihre Kontaktdaten ein, um eine Antwort zu erhalten

Es werden nur Ihr Name und Ihre Frage veröffentlicht.

Meinungen

Erfolge dieses Bildungszentrums

2020

Sämtlich Kurse sind auf dem neuesten Stand

Die Durchschnittsbewertung liegt über 3,7

Mehr als 50 Meinungen in den letzten 12 Monaten

Dieses Bildungszentrum ist seit 16 Mitglied auf Emagister

Inhalte

Detailed programme Course: Day 1: from 16:00 to 18:40 CET | Day 2: from 9:00 to 13:00 CET
Patentability of microbiomes Patentability of vaccines
Patentability of vaccines
Second medical uses
  • patient groups
  • contraindications
  • mechanism of action
  • degree of purity of the compound
  • enantiomers
  • plausibility
  • data requirements and tentative certainty
  • Next generation sequencing
    Effectively claiming priority
    Problem-solution-approach
  • closest prior art
  • technical effect
  • obviousness
  • Patenting antibodies
  • scope of claims
  • problems with epitope-based definitions
  • functional modifications of antibodies
  • methods of making antibodies
  • antibody formulations
  • the EPO's new Guidelines for patenting antibodies
  • Adaption of the description: the EPO's new ideas
    Enlarged Board of Appeal
  • G 1/21
  • petitions for review

  • Detailed programme Course: Day 1: from 16:00 to 18:40 CET | Day 2: from 9:00 to 13:00 CET
    Patentability of microbiomes Patentability of vaccines
    Patentability of vaccines
    Second medical uses
  • patient groups
  • contraindications
  • mechanism of action
  • degree of purity of the compound
  • enantiomers
  • plausibility
  • data requirements and tentative certainty
  • Next generation sequencing
    Effectively claiming priority
    Problem-solution-approach
  • closest prior art
  • technical effect
  • obviousness
  • Patenting antibodies
  • scope of claims
  • problems with epitope-based definitions
  • functional modifications of antibodies
  • methods of making antibodies
  • antibody formulations
  • the EPO's new Guidelines for patenting antibodies
  • Adaption of the description: the EPO's new ideas
    Enlarged Board of Appeal
  • G 1/21
  • petitions for review

  • Detailed programme
    Detailed programme
    Course: Day 1: from 16:00 to 18:40 CET | Day 2: from 9:00 to 13:00 CET

    Course: Day 1: from 16:00 to 18:40 CET | Day 2: from 9:00 to 13:00 CET
    Patentability of microbiomes Patentability of vaccines
    Patentability of vaccines
    ...

    Online Course: Recent Decisions of the EPO Boards of Appeal in Biotechnology and Biopharmaceuticals

    Preis auf Anfrage